1. Home
  2. MX vs KYTX Comparison

MX vs KYTX Comparison

Compare MX & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MX
  • KYTX
  • Stock Information
  • Founded
  • MX 2003
  • KYTX 2018
  • Country
  • MX South Korea
  • KYTX United States
  • Employees
  • MX N/A
  • KYTX N/A
  • Industry
  • MX Semiconductors
  • KYTX
  • Sector
  • MX Technology
  • KYTX
  • Exchange
  • MX Nasdaq
  • KYTX NYSE
  • Market Cap
  • MX 145.3M
  • KYTX 119.7M
  • IPO Year
  • MX N/A
  • KYTX 2024
  • Fundamental
  • Price
  • MX $4.14
  • KYTX $4.33
  • Analyst Decision
  • MX Strong Buy
  • KYTX Strong Buy
  • Analyst Count
  • MX 1
  • KYTX 5
  • Target Price
  • MX $6.00
  • KYTX $19.00
  • AVG Volume (30 Days)
  • MX 150.6K
  • KYTX 599.4K
  • Earning Date
  • MX 07-31-2025
  • KYTX 08-11-2025
  • Dividend Yield
  • MX N/A
  • KYTX N/A
  • EPS Growth
  • MX N/A
  • KYTX N/A
  • EPS
  • MX N/A
  • KYTX N/A
  • Revenue
  • MX $233,021,000.00
  • KYTX N/A
  • Revenue This Year
  • MX N/A
  • KYTX N/A
  • Revenue Next Year
  • MX $7.05
  • KYTX N/A
  • P/E Ratio
  • MX N/A
  • KYTX N/A
  • Revenue Growth
  • MX 7.64
  • KYTX N/A
  • 52 Week Low
  • MX $2.51
  • KYTX $1.78
  • 52 Week High
  • MX $5.98
  • KYTX $10.08
  • Technical
  • Relative Strength Index (RSI)
  • MX 53.89
  • KYTX 63.84
  • Support Level
  • MX $3.81
  • KYTX $3.80
  • Resistance Level
  • MX $4.32
  • KYTX $4.39
  • Average True Range (ATR)
  • MX 0.15
  • KYTX 0.39
  • MACD
  • MX 0.00
  • KYTX 0.05
  • Stochastic Oscillator
  • MX 47.10
  • KYTX 93.78

About MX Magnachip Semiconductor Corporation

MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

Share on Social Networks: